Summary
CVS Health Corp. (CVS) announced a significant development with the entry into a definitive Agreement and Plan of Merger with Longs Drug Stores Corporation. This filing details a tender offer by CVS's subsidiary, Blue MergerSub Corp., to acquire all outstanding shares of Longs Drug Stores for $71.50 per share in cash. Following a successful tender offer, a merger will take place, making Longs a wholly owned subsidiary of CVS. This strategic move aims to expand CVS's retail pharmacy footprint and market presence. The transaction is not subject to a financing condition, which is positive for deal certainty. However, it is contingent on customary closing conditions, including antitrust approvals (Hart-Scott-Rodino) and a minimum tender condition requiring at least two-thirds of Longs' outstanding shares to be tendered. CVS has also secured an option to purchase additional Longs shares under certain conditions to facilitate a potential short-form merger. The agreement includes provisions for termination fees and restrictive covenants for Longs regarding unsolicited takeover proposals, signaling a strong commitment from both parties to complete the transaction.
Key Highlights
- 1CVS Health (CVS) enters into a definitive Agreement and Plan of Merger with Longs Drug Stores Corporation.
- 2CVS's subsidiary will commence a tender offer to acquire all Longs Drug Stores shares at $71.50 per share in cash.
- 3The acquisition aims to integrate Longs Drug Stores into CVS's operations, expanding its retail pharmacy network.
- 4The offer is not contingent on financing, reducing a key risk for deal completion.
- 5Key closing conditions include antitrust approval (Hart-Scott-Rodino) and a minimum tender threshold of two-thirds of Longs' outstanding shares.
- 6CVS has obtained an option to acquire additional Longs shares to potentially enable a short-form merger.
- 7Longs is restricted from soliciting or engaging with competing takeover proposals, subject to certain exceptions.